Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: Int J Cancer. 2011 Feb 15;128(4):951–961. doi: 10.1002/ijc.25410

Table 1.

“Calcusyn” analysis reveals synergistic interactions between dasatinib and curcumin in variety of human colon cancer cells

COMBINATION THERAPY COMBINATION INDEX (CI)
Das (μM) Cur (μM) HCT-116 (p53 wt) HCT-116 (p53 null) HT-29 SW-620
0.25 2.5 0.14 0.25 0.29 1.09
0.5 5.0 0.17 0.56 0.51 0.71
1.0 10.0 0.23 0.53 0.77 0.86
2.0 20.0 0.32 0.92 1.16 0.71
4.0 40.0 0.65 1.2 1.86 0.45

CI; Combination Index < 1.0 suggests synergy